Published in Front Cell Infect Microbiol on August 19, 2015
Saliva in the diagnosis of diseases. Int J Oral Sci (2016) 0.80
Inflammatory Cytokines Interleukin-1β and Tumour Necrosis Factor-α - Novel Biomarkers for the Detection of Periodontal Diseases: a Literature Review. J Oral Maxillofac Res (2016) 0.78
Metaproteomics of saliva identifies human protein markers specific for individuals with periodontitis and dental caries compared to orally healthy controls. PeerJ (2016) 0.75
Validity of a New Kit Measuring Salivary Lactate Dehydrogenase Level for Screening Gingivitis. Dis Markers (2017) 0.75
Integrated Biomarker Profiling of Smokers with Periodontitis. J Clin Periodontol (2016) 0.75
Salivary and serum adiponectin and C-reactive protein levels in acute myocardial infarction related to body mass index and oral health. J Periodontal Res (2016) 0.75
Diagnosing peri-implant disease using the tongue as a 24/7 detector. Nat Commun (2017) 0.75
Phases of biomarker development for early detection of cancer. J Natl Cancer Inst (2001) 10.37
Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis (2012) 3.92
Methods for collecting saliva. Ann N Y Acad Sci (1993) 3.65
Preparing for precision medicine. N Engl J Med (2012) 3.34
Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest (1976) 3.21
The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer. J Natl Cancer Inst (2003) 3.08
Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm (2006) 2.72
Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48
Inflammatory biomarkers in coronary artery disease. J Cardiol (2009) 2.14
The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 (1997) 2.10
Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88
Current developments in salivary diagnostics. Biomark Med (2010) 1.83
Molecular differences between chronic and aggressive periodontitis. J Dent Res (2013) 1.66
Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 (2009) 1.66
Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res (2007) 1.65
Risk factors for periodontitis. J Int Acad Periodontol (2005) 1.63
Direct measurement of alcohol and its metabolites. Addiction (2003) 1.63
Revolutionizing medicine in the 21st century through systems approaches. Biotechnol J (2012) 1.60
Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol 2000 (2010) 1.59
Chemokine regulation of inflammation during acute viral infection. Curr Opin Allergy Clin Immunol (2003) 1.42
Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol (2009) 1.39
Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res (2011) 1.37
Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med (2013) 1.25
The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine (2002) 1.25
The inflammophilic character of the periodontitis-associated microbiota. Mol Oral Microbiol (2014) 1.25
Changes in gingival crevicular fluid inflammatory mediator levels during the induction and resolution of experimental gingivitis in humans. J Clin Periodontol (2010) 1.24
Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol (2011) 1.22
P4 medicine: how systems medicine will transform the healthcare sector and society. Per Med (2013) 1.22
Pathways for bone loss in inflammatory disease. Curr Osteoporos Rep (2012) 1.19
Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J Periodontol (2009) 1.17
Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol (2010) 1.17
Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis. J Periodontal Res (1993) 1.15
Macrophage inflammatory protein-1alpha: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease? J Periodontol (2009) 1.15
Gingivitis. J Clin Periodontol (1986) 1.14
Interleukin 1 genetic tests provide no support for reduction of preventive dental care. J Am Dent Assoc (2015) 1.14
Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res (2006) 1.09
Periodontal disease immunology: 'double indemnity' in protecting the host. Periodontol 2000 (2013) 1.06
Gene expression in periodontal tissues following treatment. BMC Med Genomics (2008) 1.05
Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J Clin Periodontol (2014) 1.03
Estimation of interleukin-1beta levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodontal Res (2003) 1.03
Inflammatory biomarkers in saliva: assessing the strength of association of diabetes mellitus and periodontal status with the oral inflammatory burden. J Clin Periodontol (2012) 1.03
Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma. Leuk Lymphoma (2005) 1.03
Clinical course of chronic periodontitis. I. Role of gingivitis. J Clin Periodontol (2003) 1.02
Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis. J Clin Periodontol (2009) 1.02
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL). Exp Hematol (2004) 1.01
Gingival inflammation and subgingival calculus as determinants of disease progression in early-onset periodontitis. J Clin Periodontol (1998) 1.00
Gingivitis as a risk factor in periodontal disease. J Clin Periodontol (2009) 0.98
Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol (2010) 0.98
Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J Periodontal Res (2000) 0.97
Utility of salivary biomarkers for demonstrating acute myocardial infarction. J Dent Res (2014) 0.96
Microscopic evaluation of clinical measurements of connective tissue attachment levels. J Clin Periodontol (1977) 0.96
Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. J Periodontal Res (2011) 0.95
The clinical course of chronic periodontitis: V. Predictive factors in periodontal disease. J Clin Periodontol (2009) 0.95
Correlation between salivary IL-1beta levels and periodontal clinical status. Arch Oral Biol (2007) 0.95
Steroid analysis in saliva: an overview. Clin Biochem Rev (2006) 0.94
Bacterial and salivary biomarkers predict the gingival inflammatory profile. J Periodontol (2011) 0.94
Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci (1999) 0.94
Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis. J Periodontol (2013) 0.94
Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol (2013) 0.94
Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res (2003) 0.93
Within-subject variability in repeated measures of salivary analytes in healthy adults. J Periodontol (2009) 0.92
The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res (2000) 0.92
Cytokine profile in the gingival crevicular fluid of periodontitis patients with and without type 2 diabetes: a literature review. J Periodontol (2011) 0.91
Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study. J Periodontol (2011) 0.90
Salivary biomarkers associated with gingivitis and response to therapy. J Periodontol (2014) 0.90
The biology, prevention, diagnosis and treatment of periodontal diseases: scientific advances in the United States. J Am Dent Assoc (2009) 0.89
Salivary protein concentration, flow rate, buffer capacity and pH estimation: A comparative study among young and elderly subjects, both normal and with gingivitis and periodontitis. J Indian Soc Periodontol (2013) 0.89
Gingival tissue transcriptomes in experimental gingivitis. J Clin Periodontol (2011) 0.88
Gingival tissue transcriptomes identify distinct periodontitis phenotypes. J Dent Res (2014) 0.87
Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects. J Clin Periodontol (2011) 0.86
Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases. J Oral Microbiol (2014) 0.86
The clinical course of chronic periodontitis. J Clin Periodontol (2004) 0.86
The gene expression profile in refractory periodontitis patients. J Periodontol (2006) 0.86
Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes. Inflamm Res (2010) 0.85
Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. J Periodontol (2011) 0.85
Salivary cortisol: a possible biomarker in evaluating stress and effects of interventions in young foster children? Eur Child Adolesc Psychiatry (2013) 0.84
Evaluation of salivary biomarker profiles following non-surgical management of chronic periodontitis. Oral Dis (2013) 0.84
Susceptibility to gingivitis: a way to predict periodontal disease? Oral Health Prev Dent (2004) 0.84
Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 0.84
Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Odontology (2011) 0.84
Whole salivary interleukin-6 and matrix metalloproteinase-8 levels in patients with chronic periodontitis with and without prediabetes. J Periodontol (2013) 0.83
Association between tumor necrosis factor-α promoter -308 A/G, -238 A/G, interleukin-6 -174 G/C and -572 G/C polymorphisms and periodontal disease: a meta-analysis. Mol Biol Rep (2013) 0.82
The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas. Cytokine (2001) 0.81
Interleukin-1 as a genetic marker for periodontitis: review of the literature. Quintessence Int (2010) 0.81
Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World J Diabetes (2014) 0.79
Local and systemic inflammatory responses to experimentally induced gingivitis. Dis Markers (2013) 0.78
Oral fluid nicotine markers to assess smoking status and recency of use. Ther Drug Monit (2011) 0.78
Morphological studies on periodontal disease in the cynomolgus monkey. III. Electron microscopic observations. J Periodontal Res (1986) 0.78
Maternal inflammatory markers and term labor performance. Am J Obstet Gynecol (2013) 0.77
Oral fluid for the detection of drugs of abuse using immunoassay and LC-MS/MS. Bioanalysis (2013) 0.77
Working out mechanisms of controlled/physiologic inflammation in the GI tract. Immunol Res (2012) 0.77
Biomarkers of rheumatoid arthritis: recent progress. Expert Opin Med Diagn (2010) 0.76
Leroy Hood looks forward to P4 medicine: predictive, personalized, preventive, and participatory. J Natl Cancer Inst (2014) 0.76